MGI Tech Partners with Cenglang Biotechnology to Deepen Expansion in the Asia-Pacific Region On December 26th, Beijing Cenglang Biotechnology Co.,Ltd. and MGI Tech reached a strategic cooperation agreemen..

Chinese molecular diagnostics and precision medicine firm GenePlus Technology said on Sunday that it has filed for an initial public offering on the Hong Kong Stock Exchange.

Singlera Genomics said on Tuesday that it has entered into a research and distribution agreement with EU-based international medical company Pure Medical for its cell-free DNA detection products

Zydus Lifesciences said on Friday that it has signed an agreement to exclusively commercialize a trio of Myriad Genetics cancer tests in India.

Guardant Health Japan said Monday that it has received approval from that country's Ministry of Health, Labour, and Welfare (MHLW) for its Guardant360 CDx as a companion diagnostic for identifying ESR1 mutations in breast cancer patients.

3.6 Construction of Quality System The standardization and quality control of thrombus and hemostasis testing methods is to perform reasonable management, testing, and assessment of the quality level of the tech..

Sansure Biotech and Health-100 Form Strategic Partnership to Advance Quantified, Precision Health Management On December 19, 2025, Sansure Biotech and Health-100 signed a strategic cooperation agreement in Shang..

Results of a Phase I clinical trial published on Tuesday demonstrate that Personalis' minimal residual disease (MRD) assay, NeXT Personal, accurately predicts immunotherapy response across multiple metastatic solid tumor cancer types.

Singlera Genomics and its partner Breakthrough Genomics this week announced a research collaboration with the University of Pittsburgh around the early detection of pancreatic cancer.

The test stems from findings by CUHK investigators — who recently cofounded MicroSigX as a spinout of the university — that certain gut microbial community features are associated with autism spectrum disorder and could be used to diagnoses the condition.

Solvd Health said Wednesday that its pharmacogenomics (PGx) test PreScript has received approval from the New York State Department of Health Clinical Laboratory Evaluation Program (CLEP).

“In the past, when we talked about sexually active populations, we mainly referred to people aged 20 to 49, who accounted for the majority of HIV infections. But now, infection rates among people aged 50 and above are increasing.” On December 1, during a World AIDS Day themed publicity event jointly organized by Guangdong Province and Guangzhou City, Han Zhigang, Director of the HIV Prevention and Control Department at the Guangzhou Center for Disease Control and Prevention, said this in an interview with Yicai.

3.5 Continuous Research and Development of New Blood Coagulation Test Items There is a huge gap between the development and popularity of coagulation test items in China and developed countries, with a huge room..

Becton Dickinson said Monday that its partner Certest Biotec has received In Vitro Diagnostic Medical Device Regulation certifications in Europe for two infectious disease assays.

AI biotechnology startup Valinor has raised $13 million in seed funding to further develop its multiomics-powered machine learning models to boost clinical trial success rates for drug development.

Roche Diagnostics’ Elecsys® Alzheimer’s disease (AD) cerebrospinal fluid (CSF) test panel has received approval from the National Medical Products Administration (NMPA) for market launch in China. This marks the first in vitro diagnostic (IVD) product in China’s neurology field to be granted Priority Review status, and it is currently the only CSF-based AD test panel approved for clinical diagnosis in the country.

Exact Sciences is building evidence on the ability of its Oncodetect minimal residual disease (MRD) test to determine the risk of distant recurrence in breast cancer patients in the hopes of expanding its adoption and reimbursement in this setting.

Helio Genomics said Monday that it has partnered to offer its LiverTrace at-home blood test for liver cancer in partnership with liver health telemedicine firm LiverRight.

DIAN Diagnostics’ In-House R&D Solid Tumor Large Panel Receives Full Marks in EMQN EQA The European Molecular Genetics Quality Network (EMQN) released the results of its ONCOGENE PANEL external quality asse..

Lunit on Monday said it has started a collaboration with Daiichi Sankyo to use its artificial intelligence-based digital pathology tools to advance translational research and biomarker discovery for two of Daiichi's oncology pipeline programs.